Application of sentinel node biopsy to gastric cancer surgery

Citation
M. Hiratsuka et al., Application of sentinel node biopsy to gastric cancer surgery, SURGERY, 129(3), 2001, pp. 335-340
Citations number
27
Categorie Soggetti
Surgery,"Medical Research Diagnosis & Treatment
Journal title
SURGERY
ISSN journal
00396060 → ACNP
Volume
129
Issue
3
Year of publication
2001
Pages
335 - 340
Database
ISI
SICI code
0039-6060(200103)129:3<335:AOSNBT>2.0.ZU;2-A
Abstract
Background. Sentinel node (SN) biopsy has been tried in the management of a va variety of cancers with the hope that it would eliminate many unnecessa ry lymph node dissections, resulting in less morbidity. This important tech nique, however has not been tried in gastric cancer surgery. The feasibilit y of SN biopsy and its accuracy in predicting the lymph node status in pati ents with gastric cancer were examined in the current study. Patients and methods. SN biopsy was performed in patients with T1 (n = 44) or T2 (n = 30) gastric cancers (ie, immediately after laparotomy, indocyani ne green was injected around the primary tumor and the green-stained nodes [SNs: 2.6 +/- 1.7 nodes per patient] were removed). Then, gastrectomy with extended lymphadenectomy was performed. The unstained nodes (non-SNs: 39 +/ - 18 nodes per-patient) were obtained from the resected specimens. Both SNs and non-SNs were subjected to histologic examination with hematoxylin-eosi n. Results. SNs could be identified in 73 of 74 patients (success rate, 99%). Of these 73 patients, 10 had lymph node metastases in SNs or non-SNs, or bo th; 6 in both SNs and non-SNs; 3 in SNs alone; and 1 in non-SNs alone. The sensitivity of the SN status in the diagnosis of the lymph node status of t he patient was 90% (9/10) and specificity was 100% (63/63). Sensitivity was 100% in the n group (n = 44) and 88 % in the T2 group (n = 23). Conclusions. SN biopsy using indocyanine green can be performed with a high success rate, and the SN status can predict the lymph node status with a h igh degree of accuracy especially in patients with T1 gastric cancer.